New Cervical Cancer Screening Guidelines Improve Access, Outcomes

New guidelines from the American Cancer Society are set to enhance cervical cancer screening, making it more accessible and effective.

The 2025 update introduces self-collection options for HPV testing, refines the age to start and stop screening, and continues to underscore the vital role of HPV vaccination in cancer prevention. These changes are designed to improve patient care, overcome barriers to screening and ultimately save more lives.

“The most recent American Cancer Society cervical cancer screening recommendations will improve patient care primarily by expanding access through self-collection options and simplifying screening exit criteria to prevent cancers in older patients,” says Ryan M. Kahn, M.D., a gynecologic oncologist with Baptist Health Miami Cancer Institute.

Expanding Access with Self-Collection

A significant development in the new guidelines is the endorsement of self-collected vaginal specimens for HPV testing. This option is an acceptable alternative to clinician-collected samples for individuals at average risk for cervical cancer, aged 25 to 65.

This change is a major step forward in making screening more accessible, Dr. Kahn says. “Many people face challenges that prevent them from getting regular screenings, such as transportation issues, work schedules or discomfort with pelvic exams.” Self-collection, which can be done at home or in a clinical setting using FDA-approved devices, helps overcome these hurdles.

Who Qualifies for Self-Collection?

Dr. Kahn points out that not all women receiving cervical cancer screenings will qualify for the self-collection option. He says self-collection is suitable for individuals who:

• Have a cervix
• Are asymptomatic, meaning they have no abnormal bleeding or other concerning symptoms
• Are either being screened for the first time or have a history of all normal screening results

While this new method offers convenience, it comes with a different screening schedule. “Patients who choose self-collection will need to be tested every three years,” Dr. Kahn says. “Clinician-collected samples, which remain the preferred method, are recommended every five years.”

New Guidance on When to Start and End Screenings

Thomas P. Morrissey, M.D., director of gynecologic oncology at Lynn Cancer Institute, part of Baptist Health at Boca Raton Regional Hospital, says the updated guidelines also provide clearer recommendations for when to begin and end screening for cervical cancer.

“If you have a cervix and are at average risk for cervical cancer, you should begin screening at age 25 and continue until at least age 65,” Dr. Morrissey says. Depending on the type of test, screening should occur every three to five years.

This change is beneficial for younger patients, he notes. “Starting at age 25 will lead to decreased rates of false-positive results and unnecessary procedures in young patients.”

Perhaps one of the most critical updates involves the criteria for discontinuing screening. Previously, the rules for when to stop were less stringent and often not well implemented, according to Dr. Morrissey, leading to a high rate of cervical cancer in individuals over 65.

To address this, the revised guidelines state that a person must have negative HPV tests at both age 60 and age 65 before safely stopping screening. This two-step confirmation ensures that the risk of developing cancer later in life is significantly reduced.

“This change addresses the high rates of cervical cancer in individuals older than 65 years and poor implementation of previous exit criteria,” says Dr. Morrissey. Discussing these changes to cervical cancer screening guidelines with your healthcare provider will help you decide which option is best for you.

The Power of Prevention: HPV Vaccination

While screening is crucial for early detection, prevention is even better. Both Dr. Kahn and Dr. Morrissey emphasize the life-saving impact of the HPV vaccine.

“The HPV vaccine saves lives. I cannot stress this enough,” Dr. Kahn asserts. “We’ve seen an incredible reduction in HPV-associated cervical cancers across the population who has undergone vaccination.”

Human papillomavirus (HPV) is the cause of most cervical cancers. The HPV vaccine targets the specific types of the virus responsible for the vast majority of these cancers.

The U.S. Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for all adolescents at ages 11–12, though it can be started as early as age 9. Catch-up vaccination is also recommended for everyone through age 26 who was not adequately vaccinated earlier.

Protecting an Entire Generation from a Preventable Cancer

The effectiveness of the HPV vaccine is remarkable, Dr. Kahn says. “Vaccination at ages 9–12 years will likely prevent more than 90% of cervical precancers and cancers. Widespread vaccination has already led to a significant drop in HPV-related cancers, protecting an entire generation from a preventable disease.”

By combining the powerful preventive measure of the HPV vaccine with more accessible and refined screening strategies, the fight against cervical cancer is stronger than ever. These new guidelines empower patients with more choices and provide a clearer path to lifelong health, ensuring that fewer individuals will face a cervical cancer diagnosis.